Growth-Transforming Program Achieve the B-Cell Specificity of Its Epstein-Barr Virus Exploits BSAP / Pax 5 To

[1]  E. Hui,et al.  Analysis of Epstein-Barr virus latent gene expression in endemic Burkitt's lymphoma and nasopharyngeal carcinoma tumour cells by using quantitative real-time PCR assays. , 2006, The Journal of general virology.

[2]  W. Hammerschmidt,et al.  Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genes , 2006, Proceedings of the National Academy of Sciences.

[3]  A. Rickinson,et al.  Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[4]  W. Hammerschmidt,et al.  Epstein-Barr Virus Provides a New Paradigm: A Requirement for the Immediate Inhibition of Apoptosis , 2005, PLoS biology.

[5]  A. Rickinson,et al.  Epstein-Barr virus-induced B-cell transformation: quantitating events from virus binding to cell outgrowth. , 2005, The Journal of general virology.

[6]  A. Rolink,et al.  Transcriptional networks in developing and mature B cells , 2005, Nature Reviews Immunology.

[7]  P. Lieberman,et al.  Dynamic Chromatin Boundaries Delineate a Latency Control Region of Epstein-Barr Virus , 2004, Journal of Virology.

[8]  K. Sugimoto,et al.  Epstein-Barr Virus Infection of Human Natural Killer Cell Lines and Peripheral Blood Natural Killer Cells , 2004, Cancer Research.

[9]  L. Yoo,et al.  Deletion of Epstein-Barr Virus Regulatory Sequences Upstream of the EBNA Gene Promoter Wp1 Is Unfavorable for B-Cell Immortalization , 2002, Journal of Virology.

[10]  P. Rivailler,et al.  Complete Nucleotide Sequence of the Rhesus Lymphocryptovirus: Genetic Validation for an Epstein-Barr Virus Animal Model , 2002, Journal of Virology.

[11]  A. Rickinson,et al.  Genetic analysis of the Epstein-Barr virus-coded leader protein EBNA-LP as a co-activator of EBNA2 function. , 2001, The Journal of general virology.

[12]  D. Thorley-Lawson,et al.  Epstein-Barr virus: exploiting the immune system , 2001, Nature Reviews Immunology.

[13]  A. Rickinson,et al.  The Epstein-Barr Virus Promoter Initiating B-Cell Transformation Is Activated by RFX Proteins and the B-Cell-Specific Activator Protein BSAP/Pax5 , 2000, Journal of Virology.

[14]  P. Ling,et al.  Conserved Regions in the Epstein-Barr Virus Leader Protein Define Distinct Domains Required for Nuclear Localization and Transcriptional Cooperation with EBNA2 , 2000, Journal of Virology.

[15]  D. Thorley-Lawson,et al.  Cells Expressing the Epstein-Barr Virus Growth Program Are Present in and Restricted to the Naive B-Cell Subset of Healthy Tonsils , 2000, Journal of Virology.

[16]  K. Rajewsky,et al.  EBV-infected B cells in infectious mononucleosis: viral strategies for spreading in the B cell compartment and establishing latency. , 2000, Immunity.

[17]  A. Rickinson,et al.  The activity of the Epstein-Barr virus BamHI W promoter in B cells is dependent on the binding of CREB/ATF factors. , 2000, The Journal of general virology.

[18]  J. Skinner,et al.  Characterisation of regulatory sequences at the Epstein-Barr virus BamHI W promoter. , 1998, Virology.

[19]  W. Hammerschmidt,et al.  Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[20]  K. Takada,et al.  Cell-to-Cell Contact as an Efficient Mode of Epstein-Barr Virus Infection of Diverse Human Epithelial Cells , 1998, Journal of Virology.

[21]  N. Cooper,et al.  Epstein-Barr  Virus Binding to CD21 Activates the Initial Viral Promoter via NF-κB Induction , 1997, The Journal of experimental medicine.

[22]  H. Yoshiyama,et al.  Epstein-Barr virus infection of human gastric carcinoma cells: implication of the existence of a new virus receptor different from CD21 , 1997, Journal of virology.

[23]  S. Speck,et al.  Regulation of EBNA gene transcription in lymphoblastoid cell lines: characterization of sequences downstream of BCR2 (Cp) , 1997, Journal of virology.

[24]  P. Farrell,et al.  Molecular genetic analysis of Epstein-Barr virus Cp promoter function , 1996, Journal of virology.

[25]  L. Young,et al.  In vitro production of stable Epstein-Barr virus-positive epithelial cell clones which resemble the virus:cell interaction observed in nasopharyngeal carcinoma. , 1996, Virology.

[26]  H. Yoshiyama,et al.  Persistent Epstein‐Barr virus infection in a human T‐cell line: unique program of latent virus expression. , 1995, The EMBO journal.

[27]  W. Hammerschmidt,et al.  Immortalization of human primary B lymphocytes in vitro with DNA. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[28]  S. Fujiwara,et al.  Isolation of Epstein-Barr virus-infected clones of the human T-cell line MT-2: use of recombinant viruses with a positive selection marker , 1995, Journal of virology.

[29]  W. Hammerschmidt,et al.  Episomal and integrated copies of Epstein-Barr virus coexist in Burkitt lymphoma cell lines , 1993, Journal of virology.

[30]  N. Cooper,et al.  Plasmacytoid differentiation of Epstein-Barr virus-transformed B cells in vivo is associated with reduced expression of viral latent genes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[31]  A. Aguzzi,et al.  Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis. , 1992, Genes & development.

[32]  L. Young,et al.  Epstein–Barr virus infection and replication in a human epithelial cell system , 1992, Nature.

[33]  M. Masucci,et al.  Methylation of discrete sites within the enhancer region regulates the activity of the Epstein-Barr virus BamHI W promoter in Burkitt lymphoma lines , 1992, Journal of virology.

[34]  U. Nater,et al.  Epstein-Barr virus. , 1991, The Journal of family practice.

[35]  E. Kieff,et al.  Early events in Epstein-Barr virus infection of human B lymphocytes. , 1991, Virology.

[36]  J. Strominger,et al.  Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[37]  D. Rowe,et al.  Size and stability of the Epstein-Barr virus major internal repeat (IR-1) in Burkitt's lymphoma and lymphoblastoid cell lines. , 1989, Virology.

[38]  A. Ricksten,et al.  The 5' flanking region of the gene for the Epstein-Barr virus-encoded nuclear antigen 2 contains a cell type specific cis-acting regulatory element that activates transcription in transfected B-cells. , 1988, Nucleic acids research.

[39]  J. Strominger,et al.  An Epstein-Barr virus transcript from a latently infected, growth-transformed B-cell line encodes a highly repetitive polypeptide. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[40]  I. Andó,et al.  EB virus induction is associated with B-cell maturation. , 1986, Immunology.

[41]  E. Kieff,et al.  Nucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: a probable transcriptional initiation site. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[42]  T. Honjo,et al.  Epstein–Barr virus transforms precursor B cells even before immunoglobulin gene rearrangements , 1984, Nature.

[43]  I. Ernberg,et al.  Epstein-Barr virus transformation of human pre-B cells , 1983, The Journal of experimental medicine.

[44]  H. Kunkel,et al.  Pre-B cells and other possible precursor lymphoid cell lines derived from patients with X-linked agammaglobulinemia , 1980, The Journal of experimental medicine.

[45]  M. Busslinger,et al.  the B-cell-specific transcription factor BSAP . The promoter of the CD 19 gene is a target for , 2022 .